Yi-Jen Liao

9PUBLICATIONS
5CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersCancer geneticsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 28, 2023
Isolation and Biological Evaluation of Alfa-Mangostin as Potential Therapeutic Agents against Liver Fibrosis.

Yi-Jen Liao, Chun-Ya Lee, Yuh-Ching Twu

|Nov 26, 2022
HMGCS2 Mediation of Ketone Levels Affects Sorafenib Treatment Efficacy in Liver Cancer Cells.

Fat-Moon Suk, Chien-Ying Wu, Wan-Chun Chiu

|Aug 27, 2021
Secretory NPC2 Protein-Mediated Free Cholesterol Levels Were Correlated with the Sorafenib Response in Hepatocellular Carcinoma.

Fat-Moon Suk, Yuan-Hsi Wang, Wan-Chun Chiu

|Apr 03, 2021
Ketogenic Diet Enhances the Cholesterol Accumulation in Liver and Augments the Severity of CCl4 and TAA-Induced Liver Fibrosis in Mice.

Yi-Jen Liao, Yuan-Hsi Wang, Chien-Ying Wu

|Oct 21, 2020
Alterations of Specific Lymphocytic Subsets with Aging and Age-Related Metabolic and Cardiovascular Diseases.

Ying Jen Chen, Yi Jen Liao, Van Thi Ngoc Tram

|Sep 09, 2020
Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.

Chao Lien Liu, Ying Jen Chen, Ming Huei Fan

Pageof 2